<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Brainwashed killers</title>
	<atom:link href="http://www.iayork.com/MysteryRays/2009/10/19/brainwashed-killers/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.iayork.com/MysteryRays/2009/10/19/brainwashed-killers/</link>
	<description>Meddling with things mankind is not meant to understand.  Also, pictures of my kids</description>
	<lastBuildDate>Thu, 29 Jul 2010 14:16:44 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
	<item>
		<title>By: Peer</title>
		<link>http://www.iayork.com/MysteryRays/2009/10/19/brainwashed-killers/comment-page-1/#comment-35102</link>
		<dc:creator>Peer</dc:creator>
		<pubDate>Mon, 26 Oct 2009 15:56:36 +0000</pubDate>
		<guid isPermaLink="false">http://www.iayork.com/MysteryRays/?p=1440#comment-35102</guid>
		<description>The effects of chemotherapeutic agents are very interesting indeed. I think that the antiproliferatives are generally immunosuppresive but the idea of hypoxic anti-tumor immune response modulation is intriguing. Hypoxia and inflammation is a very complex mixture in my opinion and just browsing the literature I started to realize how little I know.

While searching, I found it very intriguing that 1. adenosine receptor activation by adenosine produced in hypoxia matures DCs, but at the same time reduces T cell effector responses directly, 2. Contrarily to Teffs, Tregs are activated by adenosine receptor ligation, which in turn produce more adenosine 3. There is a shift towards a Th2 (if you believe in the Th1/Th2 paradigm) response.

Apparently Michail V. Sitkovsky has found his niche in T cells and hypoxia.

I am sure there is more going on than we presently know.</description>
		<content:encoded><![CDATA[<p>The effects of chemotherapeutic agents are very interesting indeed. I think that the antiproliferatives are generally immunosuppresive but the idea of hypoxic anti-tumor immune response modulation is intriguing. Hypoxia and inflammation is a very complex mixture in my opinion and just browsing the literature I started to realize how little I know.</p>
<p>While searching, I found it very intriguing that 1. adenosine receptor activation by adenosine produced in hypoxia matures DCs, but at the same time reduces T cell effector responses directly, 2. Contrarily to Teffs, Tregs are activated by adenosine receptor ligation, which in turn produce more adenosine 3. There is a shift towards a Th2 (if you believe in the Th1/Th2 paradigm) response.</p>
<p>Apparently Michail V. Sitkovsky has found his niche in T cells and hypoxia.</p>
<p>I am sure there is more going on than we presently know.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: iayork</title>
		<link>http://www.iayork.com/MysteryRays/2009/10/19/brainwashed-killers/comment-page-1/#comment-34950</link>
		<dc:creator>iayork</dc:creator>
		<pubDate>Fri, 23 Oct 2009 14:23:32 +0000</pubDate>
		<guid isPermaLink="false">http://www.iayork.com/MysteryRays/?p=1440#comment-34950</guid>
		<description>Yes, one of the major hypotheses for tumor-induced tolerance is effects on DC -- not just failure to receive maturation signals, but also active signals (like TGFbeta, and many others) that probably drive the DC into a tolerogenic state.  That said, there can also be plenty of potential activators in a tumor environment, mainly through cell death (e.g. through low oxygenation if there&#039;s not enough angiogenesis, and general increased apoptotic cells death etc); so it&#039;s not inevitable that DC will follow the tolerogenic route.  

The effect of chemotherapy on immune responsiveness, that I&#039;ve talked about here a couple of times, is proposed to be via increased immunogenicity by increasing cell death -- a difference in degree rather than kind, I think.</description>
		<content:encoded><![CDATA[<p>Yes, one of the major hypotheses for tumor-induced tolerance is effects on DC &#8212; not just failure to receive maturation signals, but also active signals (like TGFbeta, and many others) that probably drive the DC into a tolerogenic state.  That said, there can also be plenty of potential activators in a tumor environment, mainly through cell death (e.g. through low oxygenation if there&#8217;s not enough angiogenesis, and general increased apoptotic cells death etc); so it&#8217;s not inevitable that DC will follow the tolerogenic route.  </p>
<p>The effect of chemotherapy on immune responsiveness, that I&#8217;ve talked about here a couple of times, is proposed to be via increased immunogenicity by increasing cell death &#8212; a difference in degree rather than kind, I think.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: peer</title>
		<link>http://www.iayork.com/MysteryRays/2009/10/19/brainwashed-killers/comment-page-1/#comment-34915</link>
		<dc:creator>peer</dc:creator>
		<pubDate>Thu, 22 Oct 2009 23:10:19 +0000</pubDate>
		<guid isPermaLink="false">http://www.iayork.com/MysteryRays/?p=1440#comment-34915</guid>
		<description>Ian, I think tumor immunology is also interesting from the dendritic cell perspective. How does a dc receive maturation signals to present tumor antigens optimally to elicit an effector cell population? Or does it not? So that the tolerance induction is a result of the lack of dc maturation signals while presenting tumor antigens.</description>
		<content:encoded><![CDATA[<p>Ian, I think tumor immunology is also interesting from the dendritic cell perspective. How does a dc receive maturation signals to present tumor antigens optimally to elicit an effector cell population? Or does it not? So that the tolerance induction is a result of the lack of dc maturation signals while presenting tumor antigens.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: iayork</title>
		<link>http://www.iayork.com/MysteryRays/2009/10/19/brainwashed-killers/comment-page-1/#comment-34910</link>
		<dc:creator>iayork</dc:creator>
		<pubDate>Thu, 22 Oct 2009 20:37:13 +0000</pubDate>
		<guid isPermaLink="false">http://www.iayork.com/MysteryRays/?p=1440#comment-34910</guid>
		<description>Interesting question.  I think the mechanism of immunosuppression is a natural one, for the reason you say -- avoiding a chronic immune response.  Whether it&#039;s &quot;supposed&quot; to happen this way for tumors, or whether the tumors are happening to take advantage of a natural mechanism, is a much harder question (and probably is too teleological to answer very well).  I think most likely it&#039;s the latter, though -- the tumors are taking advantage of it, it&#039;s not in the body&#039;s best interest to let the tumors go.  Hard or impossible to prove, though.</description>
		<content:encoded><![CDATA[<p>Interesting question.  I think the mechanism of immunosuppression is a natural one, for the reason you say &#8212; avoiding a chronic immune response.  Whether it&#8217;s &#8220;supposed&#8221; to happen this way for tumors, or whether the tumors are happening to take advantage of a natural mechanism, is a much harder question (and probably is too teleological to answer very well).  I think most likely it&#8217;s the latter, though &#8212; the tumors are taking advantage of it, it&#8217;s not in the body&#8217;s best interest to let the tumors go.  Hard or impossible to prove, though.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: hat_eater</title>
		<link>http://www.iayork.com/MysteryRays/2009/10/19/brainwashed-killers/comment-page-1/#comment-34888</link>
		<dc:creator>hat_eater</dc:creator>
		<pubDate>Thu, 22 Oct 2009 12:21:44 +0000</pubDate>
		<guid isPermaLink="false">http://www.iayork.com/MysteryRays/?p=1440#comment-34888</guid>
		<description>A question from a layman - is it possible that this immunosuppression mechanism is an adaptation? With notable exceptions like pancreatic cancer, one can live for years with a tumor, while a powerful and prolonged immune response could kill our protohuman ancestors in weeks, not directly, but by starting a vicious cycle of weakness and starvation.</description>
		<content:encoded><![CDATA[<p>A question from a layman &#8211; is it possible that this immunosuppression mechanism is an adaptation? With notable exceptions like pancreatic cancer, one can live for years with a tumor, while a powerful and prolonged immune response could kill our protohuman ancestors in weeks, not directly, but by starting a vicious cycle of weakness and starvation.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
